Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. QGEN

Go back to Elevance Health Reports Third Quarter 2022 Results, Raises Full Year Outlook

Elevance (ELV) PT Raised to $571 at Jefferies

October 20, 2022 8:48 AM EDT

Jefferies analyst David Windley raised the price target on Elevance (NYSE: ELV) to $571.00 (from $569.00) while maintaining a Buy rating.

The analyst commented, "LV's membership growth continues to be impressive, having eclipsed UNH in total members in the last 12 months. Government growth plus solid... More

Elevance Health Inc. (ELV) Tops Q3 EPS by 37c, Beats on Revenue

October 19, 2022 6:03 AM EDT

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $7.53, $0.37 better than the analyst estimate of $7.16. Revenue for the quarter came in at $39.6 billion versus the consensus estimate of $39.26 billion.

GUIDANCE:

Elevance Health Inc. sees FY2022 EPS of $28.95.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

... More